1. Home
  2. BOLD vs PPSI Comparison

BOLD vs PPSI Comparison

Compare BOLD & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • PPSI
  • Stock Information
  • Founded
  • BOLD 2018
  • PPSI 2008
  • Country
  • BOLD United States
  • PPSI United States
  • Employees
  • BOLD N/A
  • PPSI N/A
  • Industry
  • BOLD
  • PPSI Electrical Products
  • Sector
  • BOLD
  • PPSI Industrials
  • Exchange
  • BOLD Nasdaq
  • PPSI Nasdaq
  • Market Cap
  • BOLD 33.4M
  • PPSI 38.6M
  • IPO Year
  • BOLD 2024
  • PPSI N/A
  • Fundamental
  • Price
  • BOLD $1.15
  • PPSI $3.70
  • Analyst Decision
  • BOLD Buy
  • PPSI Strong Buy
  • Analyst Count
  • BOLD 4
  • PPSI 1
  • Target Price
  • BOLD $4.00
  • PPSI $12.00
  • AVG Volume (30 Days)
  • BOLD 85.6K
  • PPSI 85.6K
  • Earning Date
  • BOLD 11-05-2025
  • PPSI 11-13-2025
  • Dividend Yield
  • BOLD N/A
  • PPSI 40.76%
  • EPS Growth
  • BOLD N/A
  • PPSI N/A
  • EPS
  • BOLD N/A
  • PPSI 2.86
  • Revenue
  • BOLD N/A
  • PPSI $31,751,000.00
  • Revenue This Year
  • BOLD N/A
  • PPSI $27.32
  • Revenue Next Year
  • BOLD N/A
  • PPSI $16.14
  • P/E Ratio
  • BOLD N/A
  • PPSI $1.29
  • Revenue Growth
  • BOLD N/A
  • PPSI 105.82
  • 52 Week Low
  • BOLD $1.00
  • PPSI $2.25
  • 52 Week High
  • BOLD $3.54
  • PPSI $6.37
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 39.64
  • PPSI 43.68
  • Support Level
  • BOLD $1.17
  • PPSI $3.34
  • Resistance Level
  • BOLD $1.18
  • PPSI $3.63
  • Average True Range (ATR)
  • BOLD 0.07
  • PPSI 0.26
  • MACD
  • BOLD -0.01
  • PPSI -0.02
  • Stochastic Oscillator
  • BOLD 51.79
  • PPSI 37.42

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

Share on Social Networks: